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Abstract 
Polylactic acid (PLA) is a polymer with an increased potential to be used in different medical applications, 
including tissue engineering and drug-carries. The use of PLA in medical applications implies the evaluation of 
the human organism's response to the polymer inserting and to its degradation products. Consequently, within 
this study, we have investigated the solubility and ADMET profiles of the short oligomers (having the molecular 
weight lower than 3000 Da) resulting in degradation products of PLA. There is a linear decrease of the molar 
solubility of investigated oligomers with molecular weight. The results that are obtained also reveal that short 
oligomers of PLA have promising pharmacological profiles and limited toxicological effects on humans. These 
oligomers are predicted as potential inhibitors of the organic anion transporting peptides OATP1B1 and 
OATP1B3, they present minor probability to affect the androgen and glucocorticoid receptors, have a weak 
potential of hepatotoxicity, and may produce eye injuries. These outcomes may be used to guide or to 
supplement in vitro and/or in vivo toxicity tests such as to enhance the biodegradation properties of the 
biopolymer. 
©2020 by the authors. This article is an open-access article distributed under the terms and conditions of the Creative Commons 
Attribution license (http://creativecommons.org/licenses/by/4.0/). 
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Introduction 
For a few decades, biopolymers are extensively in use as food additives, cosmetics, medical materials, 
water treatment chemicals, packaging, etc. Because of their intrinsic properties, especially non-cytotoxicity, 
biocompatibility and biodegradation, biopolymers are a class of materials that provides a wide range of 
applications in medicine [1]. They are considered outstanding candidates to be used for the preparation of 
many medical and body implants and also as controlled drug delivery systems. 
Polylactic acid (PLA), with the chemical formula (C3H4O2)n and illustrated in Figure 1, is one of the most 
commercially competitive polymers used for medical applications acting as biologically inert supporting 
materials as scaffolds or drug-carriers [2,3]. PLA is bio absorbable being transformed in the human 
organism by simple hydrolysis to products that can be further metabolized or excreted [4,5]. The 
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biomedical applications of the polylactic acid (PLA) are drug delivery systems, suture threads, bone fixation 
screws [3]. 
PLA is degraded in situ through hydrolysis with the production of 
oligomers which are more water-soluble. Depending on the extent of 
hydrolysis, the products can be short oligomers (OLAs) and lactic acid 
(2-hydroxypropanoic acid the monomer) [3,5]. Lactic acid is a non-
toxic compound and a biochemical intermediate in carbohydrate 
metabolism [6]. The oligomers produced from hydrolysis may act as 
catalysts and they can diffuse from the sample toward the surfaces, 
these phenomena influencing the polymer degradation [3]. The 
counter-diffusion of the larger oligomers can be the determining 
phase for biodegradation as the oligomers having large dimensions cannot diffuse fast enough. Increased 
solubility of oligomers may facilitate diffusion and consequently, the biodegradability of the polymer. 
It is already known that the degradation of biopolymers is important for controlled drug delivery 
systems and for various types of implants. Biopolymers can be degraded by random chain scission to 
oligomers with lower molecular weight [7]. The degradation products, the oligomers, may also affect the 
human organism, the effects they produce being dependent on absorption, distribution, metabolism, 
excretion and toxicity (ADMET) profile [8]. The solubility in aqueous media is one of the most important 
physicochemical characteristics influencing the ADMET properties [9,10]. The soluble degradation products 
are either metabolized or transported through the lymphatic system to the kidney to be excreted from the 
organism [11]. 
PLA is known as a biodegradable, biocompatible, non-toxic and eco-friendly polymer [12] but there is a 
recent in vitro study revealing some toxic effects of PLA [13]: PLA inhibited bioluminescence (an endpoint 
illustrating cytotoxicity in mammalian cells) with high efficiency, induced an oxidative stress response and it 
contains estrogenic compounds. To the best of our knowledge, there are no available studies concerning 
the biological effects of OLAs. Taking into account this information, the aim of this study is to predict the 
aqueous solubility and ADMET profiles for short oligomers (containing up to 40 monomeric units and 
having the molecular weight up to 3000 Da) resulted from the degradation of PLA. Our methodology is 
based on the fact that controlling agencies in the field of drug and medical devices development have 
confidence in the results obtained by the use of computational tools for the prediction of the biological 
effects. 
Method  
Within this study, we have considered short PLA oligomers (OLAs) containing from 1 to 40 lactic acid 
units. We used the SwissADME computational facility [14] to predict the values of their decimal logarithm 
of the molar solubility in water (log S) and their ADMET properties. Three methods are included in 
SwissADME to predict aqueous solubility: the Estimate SOLubility (ESOL) model [15], a method adapted 
from Ali and co-workers [16], and a method based on a system of 16 fragmental contributions modulated 
by the squared root of molecular weight implemented under FILTER-IT software, version 1.0.2 
(http://silicos-it.be.s3-website-eu-west-1.amazonaws.com/software/filter-it/1.0.2/filter-it.html). ESOL is a 
method used for estimating the aqueous solubility starting from its molecular topology [15] and is based on 
4 molecular descriptors: the computed partition coefficient (clogP), the molecular weight (MW), the number 
of rotatable bonds (RB) and the proportion of heavy atoms in aromatic systems (AP) [15]. The equation 
allowing the computation of logS taking into account these descriptors is: 
 
Figure 1. The structural 
formula of poly-lactic acid 
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Wlog 0.16 0.63 log 0.062 0.066 0.74S c P M RB AP       . (1) 
The model introduced by Ali and co-workers is based on two molecular descriptors: log P and topo-
logical polar surface area (TPSA)  [16]: 
log 1.0377log 0.021 0.4488S P TPSA      . (2) 
Besides the contribution of the other physicochemical parameters, these equations consider a linear 
decrease of the logarithm of the molar solubility coefficient with MW and log P, respectively.  
The calculation of the log S in Filter-IT software is based on the equation: 
 W i ilog 0.898 0.104S M w c      , (3) 
where wi and ci are the respective weights and counts for the fragment i, and MW is the molecular weight of 
the compound (http://silicos-it.be.s3-website-eu-west-1.amazonaws.com/software/filter-it/1.0.2/filter-
it.html).  
SwissADME computational tool uses for lipophilicity descriptor (log P) in equations (1) and (2) the value 
computed using XLOGP3 method [17]. The input for the SwissADME tool is the structure of a chemical 
compound in the simplified molecular-input line-entry system (SMILES) format. 
ADMET profiles, organ and genomic toxicity of OLAs have been predicted using admetSAR2.0  [18,19], 
Pred-h-ERG, Pred-skin [20,21], Endocrine Disruptome [22], Toxtree [23] and Carcino-PredEL [24]. We have 
selected these computational tools among the numerous available facilities, as they have the accuracy of 
prediction usually higher than 70 % and friendly interfaces and tutorials that are available for free (online or 
open-source). A short description of the considered computational tools is given in Table 1. These 
computational tools have been used for assessing the ADMET profiles and toxicological endpoints for 
numerous classes of chemicals: chito-oligomers [8], synthetic steroids [25], cosmetic ingredients [26,27], 
pesticides [26,28], water-soluble derivatives of chitosan [29]. It demonstrates their wide-ranging 
applicability. 
All the considered computational tools use as inputs SMILES (Simplified Molecular-Input Line-Entry 
System) formulas of the oligomers under investigation. These formulas have been obtained using 
ACD/ChemSketch utility (https://chemicalize.com accessed – accessed in March 2019). As it may be noticed 
from Table 1, none of these methods considers the concentration of the investigated compound when 
making predictions. This is one of the limitations of computational assessment of biological effects of 
chemicals based on expert rules and/or QSAR methods.   
For scientific graphing and data analysis we have used Origin 8.0 software. 
Results and Discussions 
PLA is a hydrophobic polymer, its aqueous solubility decreasing as its molecular weight increases [5]. 
Within this study, we have assessed the dependence of the logarithm of the molar solubility in water (log S) 
of OLAs on the molecular weight and log P, respectively. The SwissADME tool allowed to compute the 
values of the logS using the three methods described above. The obtained logS values are plotted against 
the molecular weight (Figures 2) and log P (Figures 3) and they were fitted with appropriate curves such as 
to obtain the highest values of the coefficients of determination (R squared). The equations obtained by 
data analysis are presented in Table 2. For values computed using both ESOL and Ali methods, there is a 
linear decrease in the logS values of OLAs with the MW and logP respectively, the decrease described by Ali 
method being more pronounced. The SILICOS-IT method conducts to a polynomial fit of order 3 for the 
variation of the logS with MW and log P, respectively (Table 2).  
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Table 1. Short presentation of the computational tools that were used in the present study. QSAR – Quantitative 
Structure-Activity Relationship 








Drug likeness, pharmacokinetic profile 
specifying Yes or NO for every investigated 
biological action 
72-94 [14] 
admetSAR2.0 2D QSAR 
Pharmacokinetic profiles, organ (eye, heart, 
liver) and genomic toxicity specifying the 
probability of the presence or absence of a 
biological action. 
72-77 [18,19] 
Pred-hERG 2D QSAR 
Ability of a chemical compound to inhibit the 
human ether-à-go-go related gene (hERG)K+ 




Skin sensitization potential based on multiple 
QSAR models: prediction by binary model using 
human data, binary and multiclass predictions 
of murine skin sensitization potential based on 
animal data, and binary predictions based on 
non-animal data, i.e Direct Peptide Reactivity 
Assay (DPRA), KeratinoSens, and the human 










Carcinogenic and mutagenic potential 








Figure 2. Solubility in water dependence on the molecular weight of the small oligomers of PLA: log S values 
are computed using ESOL and Ali methods (a) and SILICOS-IT method (b). Red lines correspond to the fitting 
of data, linear fit for the values obtained using ESOL and Ali methods (a) and polynomial fit of order 3 for the 
values obtained using SILICOS-IT method (b). 
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Figure 3. Solubility in water dependence on the log P values for the small oligomers of PLA: log S values are 
computed using ESOL and Ali methods (a) and SILICOS-IT method (b). Red lines correspond to the fitting of 
data, linear fit for the values obtained using ESOL and Ali methods (a) and polynomial fit of order 3 for the 
values obtained using SILICOS-IT method (b). 
Table 2. Equations corresponding to data analysis of the molar solubility in water (log S) values plotted against 
molecular weight (MW) and partition coefficient (log P) respectively for the three used methods to compute log 
S values ESOL, Ali and SILICOS-IT. 
Method/ 
Parameter 





ESOL log S =0.61-0.006 MW 0.9996 log S =-0.82-2.51log P 0.9987 
Ali log S =0.88-0.012 MW 0.9997 log S =-1.92-4.89 log P 0.9989 








 3 0.9767 






Excepting the lactic acid, no experimental data on the molar solubility of the other OLAs were available 
for comparison and for evaluating these mathematical models. Taking into account that the aqueous 
solubility of PLA decreases with increasing molecular weight [5] and the R2 values in Table 2, Ali method 
seems to be appropriate to be used to predict aqueous solubility for OLAs.  The discrepancy of the three 
prediction may come from the data sets used to derive the models for predicting the solubility values. The 
data set used to derive the ESOL model (2874 compounds, predictive ability r2 =0.72) [15] is much larger 
than the data set (1265 compounds, predictive ability  r2 = 0.869)  being used in Ali model.  The Ali model 
uses experimentally determined logP values and ESOL model uses calculated logP values (clogP). Ali and his 
co-worker  tested the ESOL model for 489 compounds with measured values for  logP, solubility and 
melting points, and there was an improvement of the model [16]. Furthermore, Ali method explicitly 
accounts for the effect of polar and polarizable atoms on aqueous solubility. The discrepancy of the 
prediction models also underlines the limitations of the in silico studies and the necessity of further 
experimental measurements such as to improve our understanding of OLAs solubility. 
We have also assessed the ADMET properties of short OLAs. Data obtained using admetSAR2.0 and 
SwissADME computational tools are illustrated in Tables 3 and 4. Numerical data represent the values of 
the probabilities that OLAs have (positive values) or have not (negative values) a certain biological action. 
Usually, there is a good correlation between the predictions obtained using the two computational tools. 
Furthermore, many of the predictions that we have obtained for OLAs are in good agreement with 
experimental literature data concerning the biological actions of PLA: estrogenic effects [13], good 
gastrointestinal absorption [32], weak potential of P-gp inhibition [33,34], binding to human serum albumin 
[35,36], penetration of the blood brain barrier [37]. 
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Table 3. ADMET properties of OLAs: GI – gastrointestinal absorption, BBBP – blood-brain barrier 
penetration, P-gps- substrate of the glycoprotein P, P-gpi- inhibitor of the glycoprotein P, PPB – plasma 
proteins binding. The numerical values in this table represent the probabilities that investigated 
oligomers have (positive values) or have not (negative values) a certain biological action. The notation 
”u” refers to the number of the monomers in the oligomer.  
Oligomer/ 
biological action 
and  tool 

















OLA 1u 0.86 high 0.95 No -1.00 -0.99 No 0.63 
OLA 2u 0.90 high 0.98 No -0.99 -0.98 No 0.63 
OLA 3u 0.90 high 0.98 No -0.99 -0.94 No 0.58 
OLA 4u 0.90 low 0.98 No -0.99 -0.85 No 0.55 
OLA 5u 0.90 low 0.98 No -0.99 -0.66 No 0.53 
OLA 6u 0.90 low 0.98 No -0.99 -0.49 No 0.52 
OLA 7u 0.90 low 0.98 No -0.99 0.62 No 0.52 
OLA 8u 0.90 low 0.98 No -0.99 0.68 No 0.51 
OLA 10u 0.90 low 0.98 No -0.99 0.73 No 0.50 
OLA 12u 0.90 low 0.98 No -0.99 0.74 No 0.50 
OLA 14u 0.90 low 0.98 No -0.99 0.74 No 0.49 
OLA 16u- OLA 
40u 
0.90 low 0.98 No -0.99 0.74 No 0.49 
Data presented in Table 3 illustrate that PLA short oligomers are predicted to have good gastrointestinal 
absorption and they are not considered substrates of the P-glycoprotein. The good gastrointestinal 
absorption of PLA has been also observed by Fernandez et al (2017) [32] by modeling the PLA nanoparticles 
absorption under gastrointestinal conditions. Their study revealed that the intestinal absorption of grape 
seed and skin extracts encapsulated in PLA nanoparticles was significantly increased. 
AdmetSAR tool reveals that oligomers containing between 7 (MW = 523 Da) and 40 (MW = 2900 Da) lactic 
acid units illustrate a mean probability to be inhibitors of P-glycoprotein, this probability increases with the 
chain length. This prediction is in good agreement with published data by Li and his co-workers (2013) [33]. 
The study of Li and co-workers revealed that copolymers of mPEG-PLA could inhibit P-gp mediated efflux 
and that concentration played a major role in the P-gp inhibition activity. Polyethylene glycol (PEG) is a 
known P-gp inhibitor [34] and the fact that the inhibitory effect on P-gp efflux of the copolymers mPEG-PLA 
having the same PEG chain length is depended on the PLA chain length, underlines that PLA also has an 
inhibitory effect on P-gp activity.  The copolymer with PLA chain length of 4802 Da was the most efficient P-
gp activity inhibitor and copolymers with longer or shorter PLA chain lengths, gradually showed weaker 
inhibitory potential on P-gp function [33]. 
There is a disparity between the predictions made by the two computational tools concerning the ability 
of OLAs to penetrate the blood-brain barrier, admetSAR predicts high probabilities of penetration of blood-
brain barrier and SwissADME outcomes reveal that OLAs are not able to penetrate this barrier. SwissADME 
tool uses for computing blood-brain–barrier permeation a model containing 260 molecules (156 permeant 
and 104 non-permeant) with reliable measurements of blood–brain partition and has a classification 
accuracy of 90 % [38]. admetSAR tool uses for predicting blood barrier penetration a binary model 
containing a higher number of compounds (1839 with 1438 permeant and 401 no-permeant), has an 
accuracy of prediction of 90.7 % and a specificity of 86.2 % [18]. The in vivo experiments proved that the 
PLA nanoparticles are able to penetrate BBB using transcytosis by microvascular endothelial cells [34].  
admetSAR2.0 tool seems to better predict the ability of the blood barrier permeation for OLAs. The 
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disagreement of the predictions made by the two computational tolls also underlines the limitations of the 
computational evaluation of the biological effects of chemicals and the necessity to perform experimental 
studies to assess this property for OLAs. 
Data from Table 3 also illustrate that the probability of OLAs to bind to plasma proteins is reduced and it 
decreases with increasing the chain length. Earlier studies revealed that lactic acid is able to bind to bovine 
serum albumin [35] and adsorption/desorption of human serum albumin at the surface of PLA 
nanoparticles (NPs) that decreased with increasing the diameter of NPs has been observed [36]. 
Table 4. Probabilities that OLAs are substrates (s) and inhibitors (i) of the human cytochromes (CYP) 
involved in the metabolism of xenobiotics. The values in this table represent the probabilities that 
investigated oligomers are (positive values) or are not (negative values) substrates or inhibitors of 
cytochromes. The notation ”u” refers to the number of the monomers in the oligomer. 
Tool/ Cytochrom/ Oligomer OLA 1u OLA 2u OLA 3u - OLA 40u 
admetSAR CYP3A4s -0.84 -0.71 -0.69 
CYP2C9s 0.60 0.60 0.60 
CYPSD6s -0.87 -0.88 -0.88 
CYP3A4i -0.98 -0.97 -0.95 
CYP2C9i -0.88 -0.91 -0.93 
CYP2C19i -0.98 -0.96 -0.97 
CYP2D6i -0.98 -0.96 -0.95 
CYP1A2i -0.97 -0.98 -0.98 
Swiss 
ADME 
CYP3A4i No No No 
CYP2C9i No No No 
CYP2C19i No No No 
CYP2D6i No No No 
CYP1A2i No No No 
Data presented in Table 4 illustrate that OLAs are not considered substrates and inhibitors of the human 
cytochromes involved in the metabolism of xenobiotics and their presence in the human organism do not 
interfere with other compounds that are metabolized by these enzymes. We were not able to find scientific 
literature mentioning the effects of OLAs or PLA on the human cytochromes. 
The probabilities corresponding to the ability of investigated OLAs to inhibit the organic anions and/or 
cations transporters are presented in Figure 4. Figure 4 illustrates that OLAs are able to inhibit the liver-
specific organic anion transporters OATP1B1 and OATP1B3. This possibility should be addressed in 
experimental studies as these transporters are of particular importance for hepatic pharmacokinetics and 
elimination of xenobiotics, and the inhibition of these transporters may result in drug–drug interactions 
[39]. 
The potential of endocrine disruption of small oligomers of OLAs has been obtained using ENDOCRINE 
DISRUPTOME computational tool and is presented in Figure 5. Oligomers containing more than 10 lactic 
acid units were too big to accommodate in the active sites of the considered nuclear receptors and the 
computations have been aborted. Investigated oligomers containing up to 7 lactic acid units present a small 
binding capacity to the androgen receptor in the antagonistic conformation, and they may produce 
reproductive dysfunctions. Oligomers containing from 6 to 10 lactic acid units may affect the glucocorticoid 
receptor. These results are in good agreement with published data, Zimmerman et al (2019) [13] illustrated 
that PLA may have estrogenic effects. 
D. Dascălu et al.  ADMET & DMPK 8(4) (2020) 425-436 
432  
 
Figure 4. Probabilities of investigated OLAs to inhibit (positive values) or not inhibit (negative values) the 
organic anions and/or cations transporters (OATP/OCT) obtained using admetSAR tool. The notation ”u” 
refers to the number of the monomers in the oligomer. 
 
Figure 5. Predictions obtained using Endocrine Disruptome computational tool to assess the endocrine 
disruption potential of investigated OLAs: AR - androgen receptor, ERα and ERβ - oestrogen receptors α and 
β, GR - glucocorticoid receptor, LXRα and LRXβ - liver X receptors α and β, PPRAα, PPRAβ and PPRAγ 
peroxisome proliferator activated receptors α, β/δ and γ, RXRα - retinoid X receptor α,  TRα and TRβ - thyroid 
receptors α and β. Both agonistic and antagonistic (an) effects for the nuclear receptors AR, ERα, ERβ and GR 
are predicted. The notation ”u” refers to the number of the monomers in the oligomer. Oligomers containing 
more than 10 lactic acid units were too big to accommodate in the active sites of the considered nuclear 
receptors and the computations have been aborted. 
The results that we have obtained for the organ and genomic toxicity of small OLAs using all considered 
computational tools mentioned above are presented in Figure 6. None of the investigated compounds 
reflects skin sensitization potential, cardiotoxicity, carcinogenicity and mutagenicity. All investigated 
oligomers are considered to be able to produce eye corrosion and smaller oligomers (from 1 to 3 lactic acid 
units) may also produce eye irritations and OLAs containing at least 5 units of lactic acids emphasize a weak 
potential of hepatotoxicity. 
Literature data reveal one case of blindness and ophthalmoplegia following a treatment of the left 
periorbital region with the subcutaneous filler of PLA [40]. In vitro and in vivo animal data illustrated that 
lactic acid has skin and eye irritation potential (PubChem, accessed in 24 of April, 2020).   
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Figure 6. Predictions of organ and genomic toxicity of small OLAs: green cells illustrate non-toxicity and 
yellow cells illustrate possible toxicological effects. The notation ”u” refers to the number of the monomers in 
the oligomer and CRG means carcinogenicty. 
Also, literature data mention non-carcinogenicity [41], non-mutagenicity [42], non-hepatotoxicity and 
non-skin sensitization potential [43] of PLA. We were not able to find information concerning the 
cardiotoxicity of this polymer and of the investigated oligomers. 
Conclusions 
Within this study, we have predicted the solubility and ADMET profiles of short oligomers of poly-lactic 
acid (containing from 1 to 40 lactic acid units, OLAs) that may be released during the degradation in the 
human organisms. The outcomes of our computational study reveal a linear decrease of the solubility of 
OLAs with molecular weight and logP respectively. The low aqueous solubility of OALs is an important 
factor limiting the hydrolysis processes and the linear decreases of logS with the molecular weight may be 
used as an evaluating tool for predicting the OLAs behaviour in aqueous environments. 
Although the oligomers of the biodegradable polymers are considered to be easily excreted through 
common metabolic pathways, their possible toxic effects need to be deeply understood and detailed 
studies must be conducted. ADMET profile assessment for investigated OLAs reveals their favourable 
pharmacological profiles and limited toxicological effects on humans. According to the outcomes of the 
computational tools that we have used, these oligomers may inhibit the organic anion transporting 
peptides OATP1B1 and/or OATP1B3, they illustrate a minor probability of affecting the androgen and 
glucocorticoid receptors, have a weak potential of hepatotoxicity, and may produce eye injuries.  
These outcomes may be used to define further experimental measurements needed to improve our 
understanding of the effects of the product of PLA degradation. 
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